Kayla J. Temple

835 total citations · 3 hit papers
20 papers, 478 citations indexed

About

Kayla J. Temple is a scholar working on Molecular Biology, Hematology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Kayla J. Temple has authored 20 papers receiving a total of 478 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 5 papers in Hematology and 4 papers in Cellular and Molecular Neuroscience. Recurrent topics in Kayla J. Temple's work include Receptor Mechanisms and Signaling (8 papers), Computational Drug Discovery Methods (4 papers) and Pharmacological Receptor Mechanisms and Effects (4 papers). Kayla J. Temple is often cited by papers focused on Receptor Mechanisms and Signaling (8 papers), Computational Drug Discovery Methods (4 papers) and Pharmacological Receptor Mechanisms and Effects (4 papers). Kayla J. Temple collaborates with scholars based in United States, United Kingdom and China. Kayla J. Temple's co-authors include Jodi M. Smith, Samantha Weiss, Ajay K. Israni, Jon J. Snyder, Jonathan Miller, Krista L. Lentine, Dzhuliyana Handarova, K. Bradbrook, Craig W. Lindsley and Anna L. Blobaum and has published in prestigious journals such as Biological Psychiatry, Journal of Medicinal Chemistry and Molecular Pharmacology.

In The Last Decade

Kayla J. Temple

20 papers receiving 478 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

OPTN/SRTR 2021 Annual Data Report: Kidney

2023 163 citations Krista L. Lentine, Jodi M. Smith et al. American Journal of Transplantation profile →
OPTN/SRTR 2022 Annual Data Report: Kidney

2024 81 citations Krista L. Lentine, Jodi M. Smith et al. American Journal of Transplantation profile →
OPTN/SRTR 2023 Annual Data Report: Kidney

2025 20 citations Krista L. Lentine, Jodi M. Smith et al. American Journal of Transplantation profile →

Peers

Countries citing papers authored by Kayla J. Temple

Since Specialization

Citations

This map shows the geographic impact of Kayla J. Temple's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kayla J. Temple with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kayla J. Temple more than expected).

Fields of papers citing papers by Kayla J. Temple

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kayla J. Temple. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kayla J. Temple. The network helps show where Kayla J. Temple may publish in the future.

Co-authorship network of co-authors of Kayla J. Temple

This figure shows the co-authorship network connecting the top 25 collaborators of Kayla J. Temple. A scholar is included among the top collaborators of Kayla J. Temple based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kayla J. Temple. Kayla J. Temple is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	OPTN/SRTR 2023 Annual Data Report: Kidney breakdown → 2025 ·American Journal of Transplantation ·Krista L. Lentine, Jodi M. Smith, Grace R. Lyden, Jonathan Miller, Sarah E. Booker, Thomas G. Dolan, Kayla J. Temple, Samantha Weiss, Dzhuliyana Handarova, Ajay K. Israni, Jon J. Snyder	20
2	Discovery of VU6008677: A Structurally Distinct Tricyclic M₄ Positive Allosteric Modulator with Improved CYP450 Profile 2024 ·ACS Medicinal Chemistry Letters ·(unknown), (unknown), Julie L. Engers, (unknown), Sichen Chang, Vincent B. Luscombe, Alice L. Rodriguez, Colleen M. Niswender, Thomas M. Bridges, Olivier Boutaud, P. Jeffrey Conn, Darren W. Engers, Craig W. Lindsley, Kayla J. Temple	2
3	Discovery of VU6016235: A Highly Selective, Orally Bioavailable, and Structurally Distinct Tricyclic M₄ Muscarinic Acetylcholine Receptor Positive Allosteric Modulator (PAM) 2024 ·ACS Chemical Neuroscience ·Julie L. Engers, (unknown), Sichen Chang, Vincent B. Luscombe, Alice L. Rodriguez, Colleen M. Niswender, Hyekyung P. Cho, Michael Bubser, (unknown), Carrie K. Jones, Weimin Peng, Jerri M. Rook, Thomas M. Bridges, Olivier Boutaud, P. Jeffrey Conn, Darren W. Engers, Craig W. Lindsley, Kayla J. Temple	1
4	OPTN/SRTR 2022 Annual Data Report: Kidney breakdown → 2024 ·American Journal of Transplantation ·Krista L. Lentine, Jodi M. Smith, Grace R. Lyden, Jonathan Miller, Thomas G. Dolan, K. Bradbrook, (unknown), Kayla J. Temple, Dzhuliyana Handarova, Samantha Weiss, Ajay K. Israni, Jon J. Snyder	81
5	OPTN/SRTR 2021 Annual Data Report: Kidney breakdown → 2023 ·American Journal of Transplantation ·Krista L. Lentine, Jodi M. Smith, Jonathan Miller, K. Bradbrook, (unknown), Samantha Weiss, Dzhuliyana Handarova, Kayla J. Temple, Ajay K. Israni, Jon J. Snyder	163
6	Discovery of structurally distinct tricyclic M4 positive allosteric modulator (PAM) chemotypes – Part 2 2021 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), (unknown), Paul K. Spearing, Julie L. Engers, Alison R. Gregro, (unknown), Sichen Chang, Vincent B. Luscombe, Alice L. Rodriguez, Hyekyung P. Cho, Colleen M. Niswender, Thomas M. Bridges, P. Jeffrey Conn, Craig W. Lindsley, Darren W. Engers, Kayla J. Temple	4
7	Discovery of a novel 3,4-dimethylcinnoline carboxamide M4 positive allosteric modulator (PAM) chemotype via scaffold hopping 2019 ·Bioorganic & Medicinal Chemistry Letters ·Kayla J. Temple, Julie L. Engers, (unknown), Alison R. Gregro, (unknown), Sichen Chang, (unknown), Vincent B. Luscombe, Alice L. Rodriguez, Colleen M. Niswender, Thomas M. Bridges, P. Jeffrey Conn, Darren W. Engers, Craig W. Lindsley	9
8	Discovery of a novel 2,3-dimethylimidazo[1,2-a]pyrazine-6-carboxamide M4 positive allosteric modulator (PAM) chemotype 2019 ·Bioorganic & Medicinal Chemistry Letters ·Kayla J. Temple, Julie L. Engers, (unknown), (unknown), Sichen Chang, Vincent B. Luscombe, (unknown), Alice L. Rodriguez, Colleen M. Niswender, Thomas M. Bridges, P. Jeffrey Conn, Darren W. Engers, Craig W. Lindsley	4
9	Discovery of structurally distinct tricyclic M4 positive allosteric modulator (PAM) chemotypes 2019 ·Bioorganic & Medicinal Chemistry Letters ·Kayla J. Temple, (unknown), Julie L. Engers, (unknown), Sichen Chang, Vincent B. Luscombe, Alice L. Rodriguez, Colleen M. Niswender, Thomas M. Bridges, P. Jeffrey Conn, Darren W. Engers, Craig W. Lindsley	6
10	M1 Muscarinic Receptors Modulate Fear-Related Inputs to the Prefrontal Cortex: Implications for Novel Treatments of Posttraumatic Stress Disorder 2019 ·Biological Psychiatry ·James Maksymetz, Max E. Joffe, Sean P. Moran, Branden J. Stansley, (unknown), Kayla J. Temple, Darren W. Engers, J. Josh Lawrence, Craig W. Lindsley, P. Jeffrey Conn	24
11	Protease-activated receptor 4 activity promotes platelet granule release and platelet-leukocyte interactions 2018 ·Platelets ·Rachel A. Rigg, Laura D. Healy, (unknown), Anh T. P. Ngo, Annachiara Mitrugno, Jevgenia Zilberman‐Rudenko, Joseph E. Aslan, Monica T. Hinds, (unknown), Terry K. Morgan, András Gruber, Kayla J. Temple, Craig W. Lindsley, Matthew T. Duvernay, Heidi E. Hamm, Owen J. T. McCarty	29
12	Synthesis and characterization of a series of chiral alkoxymethyl morpholine analogs as dopamine receptor 4 (D4R) antagonists 2016 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), (unknown), (unknown), (unknown), (unknown), Kayla J. Temple, (unknown), Anna L. Blobaum, Craig W. Lindsley, Corey R. Hopkins	21
13	Identification of the minimum PAR4 inhibitor pharmacophore and optimization of a series of 2-methoxy-6-arylimidazo[2,1-b][1,3,4]thiadiazoles 2016 ·Bioorganic & Medicinal Chemistry Letters ·Kayla J. Temple, Matthew T. Duvernay, (unknown), Anna L. Blobaum, Shaun R. Stauffer, Heidi E. Hamm, Craig W. Lindsley	6
14	Discovery, characterization and biological evaluation of a novel (R)-4,4-difluoropiperidine scaffold as dopamine receptor 4 (D4R) antagonists 2016 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), (unknown), (unknown), Kayla J. Temple, (unknown), Joel M. Harp, Anna L. Blobaum, Craig W. Lindsley, Corey R. Hopkins	14
15	Exploration of GGTase-I substrate requirements. Part 2: Synthesis and biochemical analysis of novel saturated geranylgeranyl diphosphate analogs 2016 ·Bioorganic & Medicinal Chemistry Letters ·Kayla J. Temple, (unknown), Carol A. Fierke, Richard A. Gibbs	8
16	Discoidin domain receptor 1 kinase activity is required for regulating collagen IV synthesis 2016 ·Matrix Biology ·Corina M. Borza, Yan Ru Su, (unknown), Ling Yu, (unknown), Kayla J. Temple, Marcin J. Skwark, Jens Meiler, Craig W. Lindsley, (unknown), Birgit Leitinger, Roy Zent, Ambra Pozzi	37
17	Exploration of GGTase-I substrate requirements. Part 1: Synthesis and biochemical evaluation of novel aryl-modified geranylgeranyl diphosphate analogs 2016 ·Bioorganic & Medicinal Chemistry Letters ·Kayla J. Temple, (unknown), Carol A. Fierke, Richard A. Gibbs	1
18	Contributions of Protease-Activated Receptors PAR1 and PAR4 to Thrombin-Induced GPIIbIIIa Activation in Human Platelets 2016 ·Molecular Pharmacology ·Matthew T. Duvernay, Kayla J. Temple, (unknown), Anna L. Blobaum, Shaun R. Stauffer, Craig W. Lindsley, Heidi E. Hamm	34
19	Synthesis of Non-natural, Frame-Shifted Isoprenoid Diphosphate Analogues 2016 ·Organic Letters ·Kayla J. Temple, (unknown), Carol A. Fierke, Richard A. Gibbs	3
20	Development of a Series of (1-Benzyl-3-(6-methoxypyrimidin-3-yl)-5-(trifluoromethoxy)-1H-indol-2-yl)methanols as Selective Protease Activated Receptor 4 (PAR4) Antagonists with in Vivo Utility and Activity Against γ-Thrombin 2016 ·Journal of Medicinal Chemistry ·Kayla J. Temple, Matthew T. Duvernay, (unknown), (unknown), Wenjun Wu, (unknown), Anna L. Blobaum, Shaun R. Stauffer, Heidi E. Hamm, Craig W. Lindsley	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact